Abiopharma

🔍 Zou Junming Terence (Director)

Company: Ryde Group Ltd (RYDE)

Report Date: 2026-04-07

Detailed Transactions and Holdings:

• Acquired 3,500,000 shares of Class B Ordinary Shares (Direct)
  Date: 2026-04-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16,177,175.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,500,000 shares of Class B Ordinary Shares (Direct)
  Date: 2026-04-07 | Code: J | equity_swap_involved: 0 | shares_owned_after: 16,177,175.00 | transaction_form_type: 4
• Acquired 3,500,000 shares of Class B Ordinary Shares (Direct)
  Date: 2026-04-07 | Code: J | equity_swap_involved: 0 | shares_owned_after: 16,177,175.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The Class B Ordinary Shares were issued by the issuer to the Reporting Person upon satisfaction of performance-based milestones, as described in the Issuer's Form 6-K furnished on April 7, 2026.
• F2: On April 7, 2026, the Reporting Person transferred the Class B Ordinary Shares to ABJZ Holding Ltd, a company wholly owned by the Reporting Person, for estate planning and holding purposes. This transaction represents only a change in the form of ownership and does not affect the Reporting Person's pecuniary interest in the securities. Following the reported transactions, the Reporting Person does not hold any Class B Ordinary Shares directly, and all such shares are held indirectly through ABJZ Holding Ltd.